F&G Annuities & Life faces Q1 setbacks and doubts, but its strong dividend and conservative portfolio make it undervalued.

For a complete list of holdings, visit the QQQM Holdings page » The chart below shows the one year price performance of QQQM, versus its 200 day moving average: Looking at the chart above ...

At last look, the Nasdaq, based on the NQ futures chart, is trading right at the 0.62 Fibonacci retracement level from the December high to the April low. This level is historically significant.

Boston Properties pays an annual dividend of $3.92 per share and has a dividend yield of 6.1%. SBA Communications pays an annual dividend of $4.44 per share and has a dividend yield of 1.9% ...

COIN stock shows mixed signals with short-term strength, but long-term chart resistance remains a concern pre-earnings. Discover how Matt Maley trades sharp reversals—live this Wednesday ...

Shares of Amplitude have returned +10.5% over the past month versus the Zacks S&P 500 composite's +10.6% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could ...

Futures Chart Stocks Chart Indices Chart Cryptocurrency Chart Interactive Currency Chart ... Nasdaq 100 vs. Russell 2000? Which index to own in 2025- Citi answers View all comments (1) 1 NDX-0.45% ...

The Price to Earnings ratio of 32.87 is 0.37x lower than the industry average, indicating potential undervaluation for the stock. Considering a Price to Book ratio of 9.82, which is well below the ...

95.1% of PTC shares are owned by institutional investors. Comparatively, 99.3% of Qualys shares are owned by institutional investors. 0.3% of PTC shares are owned by company insiders ...

Bitcoin (BTC) is on the cusp of breaking out relative to the Nasdaq 100 Composite, with the current BTC/Nasdaq ratio sitting at 4.96. This means it now takes nearly five Nasdaq units to match the ...

2.9% of MiNK Therapeutics shares are held by institutional investors. Comparatively, 61.7% of Atyr PHARMA shares are held by institutional investors. 20.6% of MiNK Therapeutics shares are held by ...

X4 Pharmaceuticals has a beta of 0.58, indicating that its stock price is 42% less volatile than the S&P 500. Comparatively, Pluri has a beta of 1.95, indicating that its stock price is 95% more ...